Nature Structural & Molecular Biology

Nature Structural & Molecular Biology is an academic journal publishing research articles, reviews, news and commentaries in structural biology and molecular biology, with an emphasis on papers that further a "functional and mechanistic understanding of how molecular components in a biological process work together". One of the group of Nature journals, it is published by the Nature Publishing Group, a division of Macmillan Publishers Ltd. Founded in 1994 under the title Nature Structural Biology (ISSN: 1072-8368), the journal was renamed to the present title in January 2004. Like other Nature journals, there is no external Editorial Board, with editorial decisions being made by an in-house team, although peer review by external expert referees forms a part of the review process. Nature Structural & Molecular Biology is published monthly. Articles are archived online in text and PDF formats; access is by subscription only. Its 2009 impact factor was 12.273.

Publisher
Macmillan Publishers Macmillan
Country
United States
History
Nature Structural Biology (1994–2003); Nature Structural & Molecular Biology (2004–present)
Website
http://www.nature.com/nsmb/index.html
Impact factor
12.273 (2009)

Some content from Wikipedia, licensed under CC BY-SA

Alzheimer's disease & dementia

New indication of a link between Alzheimer's and diabetes

Pathological protein clumps are characteristic of a series of diseases, such as Alzheimer's disease, Parkinson's disease, and type 2 diabetes. Scientists at Forschungszentrum Jülich, Heinrich Heine University Düsseldorf, ...

Diseases, Conditions, Syndromes

Bacterial link in celiac disease

Bacterial exposure has been identified as a potential environmental risk factor in developing coeliac disease, a hereditary autoimmune-like condition that affects about one in 70 Australians.

Diseases, Conditions, Syndromes

Potent antibody curbs Nipah and Hendra virus attack

A new monoclonal antibody has been shown to impede the fusion machinery henipaviruses use to merge with the membrane of cells they are attempting to breach. The antibody halts the attack by blocking membrane fusion and the ...

Diseases, Conditions, Syndromes

New study uncovers weakness in C. diff toxin

A new study, led by researchers from the University of California, Irvine (UCI), uncovers the long-sought-after, three-dimensional structure of a toxin primarily responsible for devastating Clostridium difficile infection ...

Diseases, Conditions, Syndromes

Survivor antibody clears path for new Ebola vaccine

An antibody taken from an Ebola survivor has been found to target all three human strains of the virus and could eventually lead to an all-purpose vaccine against the killer disease, scientists said Monday.

Parkinson's & Movement disorders

Toward a better understanding of Parkinson's disease

A new study, published today in Nature Structural and Molecular Biology, moves researchers closer to understanding one of the crucial proteins involved in Parkinson's disease.

page 1 from 5